SUBSCRIBE
SUBSCRIBE
News   Business   Deals

Eye Disease Treatment Firm OccuLogix Inc. Files To Go Public

October 19, 2005 | 
1 min read
Canada's OccuLogix Inc., whose products treat eye diseases, said on Friday it is planning to raise as much as $100 million in an initial public offering of common stock.
IPO
MORE ON THIS TOPIC
Untie the knots - Troubleshooting - problem solving concept image.
Deals
Werewolf and Ambros to tie the knot in $150M rare disease deal
August 21, 2026
 · 
2 min read
 · 
Michael Gibney
Business competitive advantage of paper plane in new competitive, competitor individual pointing in different ways for new competitive advantage on 3D render. Advantage for new idea competition.
IPO
Scribe’s early-stage IPO standout defies biotech’s derisking trend
August 20, 2026
 · 
3 min read
 · 
Gabrielle Masson
Words IPO (Initial public offering) with the trading data on the background.
IPO
2026 IPO stock tracker: How newly public biotechs are performing
August 19, 2026
 · 
1 min read
 · 
Gabrielle Masson
Business negotiation, deal making or acquisition, merger vector concept. Two men shaking hands. Minimal design. Eps10 illustration
Manufacturing
Sandoz inks $322M Henlius deal for rights to as many as 10 biosimilars
August 18, 2026
 · 
2 min read
 · 
Nick Paul Taylor